Course Provider
Learning Objectives
1. Define Alpha-1 Antitrypsin Deficiency, including its genetic components and phenotypes.
2. Identify the three primary systems affected by Alpha-1 Antitrypsin Deficiency.
3. Distinguish the clinical manifestations of Alpha-1 Antitrypsin Deficiency on lung and liver disease.
4. Identify current augmentation therapy options.